GLAND PHARMA LIMITED Unclassified
FDA Approved Drugs

GLAND PHARMA LIMITED Unclassified

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Unclassified
  • Total Records 10
  • Latest Approval Date -
  • Data Source FDA
  • First Approval Date -
All
240
View
Unclassified
10
View
Discontinued
6
View
OTC
4
View
RX
220
View
Company Overview

Company

GLAND PHARMA LIMITED Unclassified

Country

India

Social Profiles

Company Snapshot

GLAND PHARMA LIMITED Unclassified

6-3-865/1/2, Greenland Apartments Ameerpet, Hyderabad - 500016

India

glandpharma.com/ gland@glandpharma.com View on Map
FDA Approved Drug Records ( 10 records )
-
Unclassified Application: 209797

Drug Name

BIMATOPROST

Product Number

1

Dosage Form

-

Strength

0.01%

Approval Date

-

209797 / 1

Active Ingredient

BIMATOPROST

Application Number

209797

Product Number

1

Dosage Form

-

Strength

0.01%

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 76722

Drug Name

KETOROLAC TROMETHAMINE

Product Number

3

Dosage Form

-

Strength

60MG/2ML

Approval Date

-

76722 / 3

Active Ingredient

KETOROLAC TROMETHAMINE

Application Number

76722

Product Number

3

Dosage Form

-

Strength

60MG/2ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 216855

Drug Name

NETARSUDIL MESYLATE

Product Number

1

Dosage Form

-

Strength

0.02%

Approval Date

-

216855 / 1

Active Ingredient

NETARSUDIL

Application Number

216855

Product Number

1

Dosage Form

-

Strength

0.02%

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219632

Drug Name

ZINC SULFATE HEPTAHYDRATE, CUPRIC SULFATE, MANGANESE SULFATE, SELENIOUS ACID

Product Number

1

Dosage Form

-

Strength

55UG/1ML

Approval Date

-

219632 / 1

Active Ingredient

ZINC SULFATE HEPTAHYDRATE, CUPRIC SULFATE, MANGANESE SULFATE, SELENIOUS ACID

Application Number

219632

Product Number

1

Dosage Form

-

Strength

55UG/1ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219632

Drug Name

ZINC SULFATE HEPTAHYDRATE, CUPRIC SULFATE, MANGANESE SULFATE, SELENIOUS ACID

Product Number

2

Dosage Form

-

Strength

0.3MG/1ML

Approval Date

-

219632 / 2

Active Ingredient

ZINC SULFATE HEPTAHYDRATE, CUPRIC SULFATE, MANGANESE SULFATE, SELENIOUS ACID

Application Number

219632

Product Number

2

Dosage Form

-

Strength

0.3MG/1ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219632

Drug Name

ZINC SULFATE HEPTAHYDRATE, CUPRIC SULFATE, MANGANESE SULFATE, SELENIOUS ACID

Product Number

3

Dosage Form

-

Strength

60UG/1ML

Approval Date

-

219632 / 3

Active Ingredient

ZINC SULFATE HEPTAHYDRATE, CUPRIC SULFATE, MANGANESE SULFATE, SELENIOUS ACID

Application Number

219632

Product Number

3

Dosage Form

-

Strength

60UG/1ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219632

Drug Name

ZINC SULFATE HEPTAHYDRATE, CUPRIC SULFATE, MANGANESE SULFATE, SELENIOUS ACID

Product Number

4

Dosage Form

-

Strength

3MG/1ML

Approval Date

-

219632 / 4

Active Ingredient

ZINC SULFATE HEPTAHYDRATE, CUPRIC SULFATE, MANGANESE SULFATE, SELENIOUS ACID

Application Number

219632

Product Number

4

Dosage Form

-

Strength

3MG/1ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219632

Drug Name

ZINC SULFATE HEPTAHYDRATE, CUPRIC SULFATE, MANGANESE SULFATE, SELENIOUS ACID

Product Number

5

Dosage Form

-

Strength

1000UG/1ML

Approval Date

-

219632 / 5

Active Ingredient

ZINC SULFATE HEPTAHYDRATE, CUPRIC SULFATE, MANGANESE SULFATE, SELENIOUS ACID

Application Number

219632

Product Number

5

Dosage Form

-

Strength

1000UG/1ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219632

Drug Name

ZINC SULFATE HEPTAHYDRATE, CUPRIC SULFATE, MANGANESE SULFATE, SELENIOUS ACID

Product Number

6

Dosage Form

-

Strength

6UG/1ML

Approval Date

-

219632 / 6

Active Ingredient

ZINC SULFATE HEPTAHYDRATE, CUPRIC SULFATE, MANGANESE SULFATE, SELENIOUS ACID

Application Number

219632

Product Number

6

Dosage Form

-

Strength

6UG/1ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219632

Drug Name

ZINC SULFATE HEPTAHYDRATE, CUPRIC SULFATE, MANGANESE SULFATE, SELENIOUS ACID

Product Number

7

Dosage Form

-

Strength

3UG/1ML

Approval Date

-

219632 / 7

Active Ingredient

ZINC SULFATE HEPTAHYDRATE, CUPRIC SULFATE, MANGANESE SULFATE, SELENIOUS ACID

Application Number

219632

Product Number

7

Dosage Form

-

Strength

3UG/1ML

Approval Date

-

Regulatory Status

Unclassified

Related Databases
  • FDA Inspections
    25 View
  • EDQM CEP
    3 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    3 View
  • FDA Approved Drugs Database
    240 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
10 total
  • Unclassified
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

BIMATOPROST

Application Number

209797

Product Number

1

Active Ingredient

BIMATOPROST

Dosage Form

-

Strength

0.01%

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.